Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Long-term safety of drug-eluting stents in off-label use

Long-term safety of drug-eluting stents in off-label use

Advances in clinical cardiology

Advances in clinical cardiology

Adding estradiol to a polymer-free rapamycin-eluting stent is not associated with any measurable benefit

Adding estradiol to a polymer-free rapamycin-eluting stent is not associated with any measurable benefit

Plavix appears to be safe during and after heart bypass

Plavix appears to be safe during and after heart bypass

Researchers create roadmap to integrin activation

Researchers create roadmap to integrin activation

How effective is continued Plavix therapy in patients undergoing a repeat stent procedure?

How effective is continued Plavix therapy in patients undergoing a repeat stent procedure?

FDA approves Plavix for STEMI heart attacks

FDA approves Plavix for STEMI heart attacks

Sanofi-aventis and Bristol-Myers Squibb agree to settle patent dispute with Apotex

Sanofi-aventis and Bristol-Myers Squibb agree to settle patent dispute with Apotex

Researchers evaluate efficacy, safety of anti-clotting drugs

Researchers evaluate efficacy, safety of anti-clotting drugs

Clopidogrel reduces risk of adverse events for patients with acute coronary syndromes undergoing balloon angioplasty

Clopidogrel reduces risk of adverse events for patients with acute coronary syndromes undergoing balloon angioplasty

New device for fixing holes in hearts of young stroke patients

New device for fixing holes in hearts of young stroke patients

Physicians slow to prescribe newer heart drugs

Physicians slow to prescribe newer heart drugs

Lack of aggressive treatment for clogged leg blood vessels means missed heart attack prevention opportunity

Lack of aggressive treatment for clogged leg blood vessels means missed heart attack prevention opportunity

Real-world treatment of patients with acute coronary syndromes

Real-world treatment of patients with acute coronary syndromes

Part of largest randomised international trial program ever conducted in atrial fibrillation (AF) discontinued

Part of largest randomised international trial program ever conducted in atrial fibrillation (AF) discontinued

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

World's largest study on acute coronary syndromes

World's largest study on acute coronary syndromes

Medication before angiograph significantly reduces risk of heart attack

Medication before angiograph significantly reduces risk of heart attack

Latest findings on aspirin resistance

Latest findings on aspirin resistance

New drug combo helps prevent strokes

New drug combo helps prevent strokes